BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Gallup, R. The MMR question [letter]. Lancet 2000 Jul 8;356(9224):161­2.
Garpenholt O, Hugosson S, Fredlund H, Giesecke J, Olcen P. Invasive disease due to Haemophilus influenzae type b during the first six years of general
vaccination of Swedish children [see comments]. Acta Paediatr 2000 Apr;89(4):471­4.
Gavrilin GV, Cherkasova EA, Lipskaya GY, Kew OM, Agol VI. Evolution of circulating wild poliovirus and of vaccine­derived poliovirus in an
immunodeficient patient: a unifying model. J Virol 2000 Aug;74(16):7381­90.
Gay, N. J. Eliminating measles­­no quick fix [editorial; comment] Bull World Health Organ 2000;78(8):949
Gdalevich M, Ephros M, Mimouni D, Grotto I, Shpilberg O, Eldad A, Ashkenazi I. Measles epidemic in israel­successful containment in the military. Prev
Med 2000 Dec;31(6):649­51
Gershon A. Varicella: to vaccinate or not vaccinate? [letter]. Arch.Dis.Child 2000;88.
Gershon, A. A.; Perkin, R. T. Herpes zoster [letter]. N Engl J Med 2000 Jul 20;343(3):222; discussion 223.
Gessner BD. The cost­effectiveness of a hypothetical respiratory syncytial virus vaccine in the elderly. Vaccine 2000;1485­94.
Gherardi MM, Ramirez JC, Esteban M. Interleukin­12 (IL­12) enhancement of the cellular immune response against human immunodeficiency virus type 1
env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL­12 boost are mediated by nitric
oxide. J Virol 2000 Jul;74(14):6278­86.
Ghosh, A. K. Evidence­based nephrology: efficacy of hepatitis B vaccine in hemodialysis patients. Int J Artif Organs 2000 Apr;23(4):282­3
Ginsberg AM. A proposed national strategy for tuberculosis vaccine development. Clin Infect Dis 2000 Jun;30 Suppl 3:S233­42.
Glassroth J. Clinical considerations in designing trials of vaccines for tuberculosis. Clin Infect Dis 2000 Jun;30 Suppl 3:S229­32.
Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA
2000;499­505.
Glinyenko VM, Abdikarimov ST, Firsova SN, Sagamonjan EA, Kadirova R, Nuorti JP et al. Epidemic diphtheria in the Kyrgyz Republic, 1994­1998. J Infect
Dis 2000; 181 Suppl 1:S98­S103.
Golaz A, Hardy IR, Glushkevich TG, Areytchiuk EK, Deforest A, Strebel P et al. Evaluation of a single dose of diphtheria­tetanus toxoids among adults in
Odessa, Ukraine, 1995: immunogenicity and adverse reactions. J Infect Dis 2000; 181 Suppl 1:S203­S207.
Golaz A, Hardy IR, Strebel P, Bisgard KM, Vitek C, Popovic T et al. Epidemic diphtheria in the Newly Independent States of the Former Soviet Union:
implications for diphtheria control in the United States. J Infect Dis 2000; 181 Suppl 1:S237­S243.
Golaz A, Lance­Parker S, Welty T, Schaefer L, Volmer L, LaFromboise C, Dixon J, Haase T, Kim C, Popovic T, et al. Epidemiology of diphtheria in South
Dakota. S D J Med 2000 Jul;53(7):281­5.
Gold M, Goodwin H, Botham S, Burgess M, Nash M, Kempe A. Re­vaccination of 421 children with a past history of an adverse vaccine reaction in a special
immunisation service. Arch Dis Child 2000 Aug;83(2):128­31.
Goldblatt D. Conjugate vaccines [editorial]. Clin.Exp.Immunol. 2000;1­3.
Gomi Y, Imagawa T, Takahashi M, Yamanishi K. Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62
and its transactivation activity. J Med Virol 2000 Aug;61(4):497­503.
Gonik B, Jones T, Contreras D, Fasano N, Roberts C. The obstetrician­gynecologist's role in vaccine­preventable diseases and immunization. Obstet Gynecol
2000 Jul;96(1):81­4.
Gonzalez M, Pirez MC, Ward E, Dibarboure H, Garcia A, Picolet H. Safety and immunogenicity of a paediatric presentation of an influenza vaccine. Arch Dis
Child 2000 Dec;83(6):488­91
Goodman, K. J.; Wu, J. S.; Frerichs, R. R. Compliance With Childhood Immunizations in Kern County, California. J Immigr Health; 2 (4): 213­222; October,
2000.
Gotch F, Rutebemberwa A, Jones G, Imami N, Gilmour J, Kaleebu P, Whitworth J. Vaccines for the control of HIV/AIDS. Trop Med Int Health 2000
Jul;5(7):A16­21.
Grabenstein JD. How hard is it to learn to vaccinate? J Am Pharm Assoc (Wash) 2000; 40(2):268.
Grabenstein JD. Smoking and the need for vaccination. J Am Pharm Assoc 2000 Jul­2000 Aug 31;40(4):562.
Gray­Grant D. Beware of all types of bat exposure, BC MDs warned [news]. CMAJ 2000 Jun 27;162(13):1862­3.
Green, M. S. Compliance with influenza vaccination and the health belief model Isr.Med.Assoc.J. 2000, 2 (12): 912­913.
Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit
Care Med 2000 Jul;162(1):167­73.
Greenberg SB. 'Bacilli and bullets': William Osler and the antivaccination movement. South Med J 2000 Aug;93(8):763­7.
Greenberg, D. S. Short of vaccine, the Pentagon slows anthrax inoculations [news] Lancet 2000 Aug 5;356(9228):491
Greensfelder L. Infectious diseases. Polio outbreak raises questions about vaccine. Science. 2000 Dec 8;290(5498):1867­9.
Griffin DD, Kirkwood CD, Parashar UD, Woods PA, Bresee JS, Glass RI, Gentsch JR. Surveillance of rotavirus strains in the United States: identification of
unusual strains. The National Rotavirus Strain Surveillance System collaborating laboratories. J Clin Microbiol 2000 Jul;38(7):2784­7.
Griskevica A, Ching P, Russo G, Kreysler J. Diphtheria in Latvia, 1986­1996. J Infect Dis 2000; 181 Suppl 1:S60­S64.
Grubeck­Loebenstein B, Blasko I, Marx FK, Trieb I. Immunization with beta­amyloid: could T­cell activation have a harmful effect? [letter]. Trends Neurosci.
2000;114.
Gruber T, Marada R. Improving pneumococcal vaccination rates for elderly patients. N.J.Med. 2000;35­9.
Gryseels B. Schistosomiasis vaccines: a devils' advocate view. Parasitol.Today 2000;46­8.
Guillemin, J. Anthrax: the investigation of a deadly outbreak [letter] N Engl J Med 2000 Oct 19;343(16):1198
Guillot S, Caro V, Cuervo N, Korotkova E, Combiescu M, Persu A, Aubert­Combiescu A, Delpeyroux F, Crainic R. Natural genetic exchanges between
vaccine and wild poliovirus strains in humans. J Virol 2000 Sep;74(18):8434­43.
Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert­Combiescu, A., Delpeyroux, F., and Crainic, R. Natural genetic exchanges
between vaccine and wild poliovirus strains in humans. J Virol 2000 Sep;74(18):8434­43
Gurunathan, S., Wu, C. Y., Freidag, B. L., and Seder, R. A. DNA vaccines: a key for inducing long­term cellular immunity. Curr Opin Immunol 2000
Aug;12(4):442­7
Habib, S., Rishpon, S., and Rubin, L. Influenza vaccination among healthcare workers Isr.Med.Assoc.J. 2000, 2 (12): 899­901.
Hadfield TL, McEvoy P, Polotsky Y, Tzinserling VA, Yakovlev AA. The pathology of diphtheria. J Infect Dis 2000; 181 Suppl 1:S116­S120.
Hagan H. Vaccination could improve overall health in a high risk population [comment]. West J Med 2000; 172(1):21.
Hagan P, Doenhoff MJ, Wilson RA, Al­Sherbiny M, Bergquist R. Schistosomiasis vaccines: a response to a devils' advocate's view. Parasitol Today 2000
Aug;16(8):322­3.
Haller AA, Miller T, Mitiku M, Coelingh K. Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3,
a novel attenuated virus vaccine vector. J Virol 2000 Dec;74(24):11626­35
Halperin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, Meekison W, Parker R, Lavigne P, Barreto L. An adult formulation of a fivecomponent
acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 2000;1312­
9.
Halpern­Felsher BL, Ozer EM, Millstein SG, Wibbelsman CJ, Fuster CD, Elster AB, Irwin CE, Jr. Preventive services in a health maintenance organization:
how well do pediatricians screen and educate adolescent patients? Arch.Pediatr.Adolesc.Med. 2000;173­9.
Hampton HL. Examination of the adolescent patient. Obstet.Gynecol.Clin.North Am. 2000;1­18.